Presence of SARS-CoV-2-reactive T cells in COVID-19 patients and healthy donors
Julian Braun, Lucie Loyal, Marco Frentsch, Daniel Wendisch, Philipp Georg, Florian Kurth, Stefan Hippenstiel, Manuela Dingeldey, Beate Kruse, Florent Fauchere, Emre Baysal, Maike Mangold, Larissa Henze, Roland Lauster, Marcus A. Mall, Kirsten Beyer, Jobst Röhmel, Jürgen Schmitz, Stefan Miltenyi, Ilja Demuth, Marcel A. Müller, Martin Witzenrath, Norbert Suttorp, Florian Kern, Ulf Reimer, Holger Wenschuh, Christian Drosten, Victor M. Corman, Claudia Giesecke-Thiel, Leif Erik Sander, Andreas Thiel
doi: https://doi.org/10.1101/2020.04.17.20061440
Julian Braun
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin, Germany
Lucie Loyal
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin, Germany
Marco Frentsch
3Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin
Daniel Wendisch
4Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin
Philipp Georg
4Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin
Florian Kurth
4Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin
Stefan Hippenstiel
4Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin
Manuela Dingeldey
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin, Germany
Beate Kruse
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin, Germany
Florent Fauchere
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin, Germany
Emre Baysal
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin, Germany
Maike Mangold
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin, Germany
Larissa Henze
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin, Germany
Roland Lauster
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
5Medical Biotechnology, Institute for Biotechnology, Technische Universität Berlin
Marcus A. Mall
6Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin
12Berlin Institute of Health (BIH), Berlin, Germany
Kirsten Beyer
6Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin
Jobst Röhmel
6Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin
Jürgen Schmitz
7Miltenyi Biotec GmbH, Bergisch-Gladbach, Germany
Stefan Miltenyi
7Miltenyi Biotec GmbH, Bergisch-Gladbach, Germany
Ilja Demuth
8Interdisciplinary Metabolism Center, Biology of Aging (BoA)-group, Charité Universitätsmedizin Berlin
Marcel A. Müller
9Institute of Virology, Charité - Universitätsmedizin Berlin, Berlin, Germany
Martin Witzenrath
4Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin
Norbert Suttorp
4Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin
Florian Kern
10JPT Peptide Technologies GmbH, Berlin, Germany
11Brighton and Sussex Medical School, Department of Clinical and Experimental Medicine, Brighton, UK
Ulf Reimer
10JPT Peptide Technologies GmbH, Berlin, Germany
Holger Wenschuh
10JPT Peptide Technologies GmbH, Berlin, Germany
Christian Drosten
9Institute of Virology, Charité - Universitätsmedizin Berlin, Berlin, Germany
12Berlin Institute of Health (BIH), Berlin, Germany
Victor M. Corman
9Institute of Virology, Charité - Universitätsmedizin Berlin, Berlin, Germany
Claudia Giesecke-Thiel
13Max Planck Institute for Molecular Genetics, Berlin, Germany
Leif Erik Sander
4Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin
Andreas Thiel
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin, Germany
Posted April 22, 2020.
Presence of SARS-CoV-2-reactive T cells in COVID-19 patients and healthy donors
Julian Braun, Lucie Loyal, Marco Frentsch, Daniel Wendisch, Philipp Georg, Florian Kurth, Stefan Hippenstiel, Manuela Dingeldey, Beate Kruse, Florent Fauchere, Emre Baysal, Maike Mangold, Larissa Henze, Roland Lauster, Marcus A. Mall, Kirsten Beyer, Jobst Röhmel, Jürgen Schmitz, Stefan Miltenyi, Ilja Demuth, Marcel A. Müller, Martin Witzenrath, Norbert Suttorp, Florian Kern, Ulf Reimer, Holger Wenschuh, Christian Drosten, Victor M. Corman, Claudia Giesecke-Thiel, Leif Erik Sander, Andreas Thiel
medRxiv 2020.04.17.20061440; doi: https://doi.org/10.1101/2020.04.17.20061440
Presence of SARS-CoV-2-reactive T cells in COVID-19 patients and healthy donors
Julian Braun, Lucie Loyal, Marco Frentsch, Daniel Wendisch, Philipp Georg, Florian Kurth, Stefan Hippenstiel, Manuela Dingeldey, Beate Kruse, Florent Fauchere, Emre Baysal, Maike Mangold, Larissa Henze, Roland Lauster, Marcus A. Mall, Kirsten Beyer, Jobst Röhmel, Jürgen Schmitz, Stefan Miltenyi, Ilja Demuth, Marcel A. Müller, Martin Witzenrath, Norbert Suttorp, Florian Kern, Ulf Reimer, Holger Wenschuh, Christian Drosten, Victor M. Corman, Claudia Giesecke-Thiel, Leif Erik Sander, Andreas Thiel
medRxiv 2020.04.17.20061440; doi: https://doi.org/10.1101/2020.04.17.20061440
Subject Area
Subject Areas
- Addiction Medicine (179)
- Allergy and Immunology (431)
- Anesthesia (99)
- Cardiovascular Medicine (943)
- Dermatology (109)
- Emergency Medicine (260)
- Epidemiology (8971)
- Gastroenterology (418)
- Genetic and Genomic Medicine (1938)
- Geriatric Medicine (190)
- Health Economics (400)
- Health Informatics (1323)
- Health Policy (657)
- Hematology (212)
- HIV/AIDS (416)
- Medical Education (200)
- Medical Ethics (54)
- Nephrology (221)
- Neurology (1819)
- Nursing (108)
- Nutrition (271)
- Oncology (992)
- Ophthalmology (296)
- Orthopedics (111)
- Otolaryngology (182)
- Pain Medicine (126)
- Palliative Medicine (44)
- Pathology (265)
- Pediatrics (576)
- Primary Care Research (234)
- Public and Global Health (4111)
- Radiology and Imaging (674)
- Respiratory Medicine (548)
- Rheumatology (224)
- Sports Medicine (177)
- Surgery (207)
- Toxicology (38)
- Transplantation (109)
- Urology (80)